September 08, 2012 (Press-News.org) An increasingly common part of doing business is dealing with non-compete agreements. Salt Lake City companies may use the contracts to protect their intellectual property, trade secrets, customer lists and other business interests.
Non-compete agreements make it difficult for former employees to find similar employment in a particular field. Employees should carefully consider an agreement's conditions before signing these contracts, and may be able to challenge the terms of a non-compete agreement in court if its restrictions are unreasonably broad.
Corporations frequently request professional employees from doctors to high-level sales staff to sign non-compete agreements that restrict where and when they may work once they leave. Sometimes, these restrictions are so limiting they go beyond the reasonable scope of protecting the company's interests.
Time Frame
In Utah, companies may require employees to sign non-compete agreements. Companies can determine and negotiate the length of time a former employee must wait to either start a business in a similar field or find similar work at a different, competing firm.
Most courts agree that a period of one or two years is a reasonable amount of time to protect a business's trade secrets and other interests. Attempting to enforce a five-year restriction on the other hand may be seen as too long and thus unreasonable.
Geographical Limitations
Likewise, companies may use non-competes to restrict where a former employee may take a new position. Such a restriction helps a company to keep its competition from encroaching on its geographical region.
While non-compete agreements that include a limited geographical restriction are usually upheld in court, agreements that stipulate nationwide restrictions are more easily challenged as overreaching.
How to Negotiate a Less Restrictive Non-Compete Agreement
Employees may be able to negotiate a less restrictive contract by challenging how or if the stipulations protect the company's legitimate business interests. For example, an employee may be able to negotiate a shorter time frame for the non-compete. Valid reasons may also underpin requesting a limited geographic area especially in a larger city. It may be unreasonable for an employer to request that the non-compete cover all of Salt Lake City when the business is limited to several neighborhoods.
Additionally, Utah requires that all non-compete agreements meet several criteria to be considered valid. The agreements must:
- Be negotiated in good faith and necessary to protect the company's business interests
- Have reasonable restrictions as to scope, time frame and geography
- Be supported by consideration at the time of signing
- Give the employee time to consider its stipulations
If these criteria are not met, it may be possible for the employee to challenge the terms of a non-compete in court. Courts generally do not allow a non-compete agreement to prohibit a former employee from finding work that uses their professional abilities.
In the instance that a non-compete agreement you signed prevents you from finding a job, please contact an experienced employment attorney who can advise whether there may be grounds to challenge the terms of the non-compete agreement in court.
Article provided by Stavros Law, P.C.
Visit us at www.stavroslaw.com/
Effective Use of Utah Non-Compete Agreements
Does your non-compete prevent you from obtaining a new job in your field? You may be able to challenge its terms in court.
2012-09-08
ELSE PRESS RELEASES FROM THIS DATE:
Amid Recalls, Questions Abound About Metal-on-Metal Hip Implants
2012-09-08
The federal Food and Drug Administration (FDA) has recently convened a special advisory panel to deal with the ongoing issues arising from a number of metal-on-metal hip replacement components. An 18-member panel comprised of physicians and medical experts from around the country met to discuss the unique complications arising from the implantation of a number of different replacement hip components manufactured and distributed by:
- Johnson & Johnson/DePuy Orthopedics
- Biomet
- Wright Medical
- Zimmer Holdings
- Encore Medical
- Smith & Nephew
More recently ...
Florida Child Relocation: How Do You Measure a 50-Mile Move?
2012-09-08
When a child's parents are unmarried, whether through divorce or because they never chose to marry, moving the child's primary residence through parent relocation can be legally complicated. For example, if the child lives with the father in Pensacola and the mother lives nearby and regularly spends time with the child, and the father gets a job offer in Miami, may he move away with the child? The 600 miles between the parents would clearly interfere with the relationship of the child and the mother.
Florida Relocation Law
The Florida statute that controls child relocation ...
Standard chemotherapy provides equivalent survival rate to experimental in lung cancer patients
2012-09-07
Treatment with pemetrexed, carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab (Pem+Cb+B) is no better than standard therapy with paclitaxel, carboplatin and bevacizumab followed by bevacizumab (Pac+Cb+B) in patients with advanced non-squamous non-small cell lung cancer (NS-NSCLC), according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association ...
Rust never sleeps
2012-09-07
Rust – iron oxide – is a poor conductor of electricity, which is why an electronic device with a rusted battery usually won't work. Despite this poor conductivity, an electron transferred to a particle of rust will use thermal energy to continually move or "hop" from one atom of iron to the next. Electron mobility in iron oxide can hold huge significance for a broad range of environment- and energy-related reactions, including reactions pertaining to uranium in groundwater and reactions pertaining to low-cost solar energy devices. Predicting the impact of electron-hopping ...
Alzheimer's experts from Penn Summit provide strategic roadmap to tackle the disease
2012-09-07
PHILADELPHIA –This week, a strategic roadmap to help to the nation's health care system cope with the impending public health crisis caused Alzheimer's disease and related dementia will be published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. The plan aims to link the latest scientific findings with clinical care and bring together patients, families, scientists, pharmaceutical companies, regulatory agencies, and advocacy organizations behind a common set of prioritized goals. The consensus document is the outcome of a June meeting of leading ...
Lack of support for 'ring-fencing' cancer drugs fund revealed
2012-09-07
The public oppose the cancer drugs fund but support the new pricing system for branded medicines, according to a new study.
When asked if the NHS should pay more for cancer drugs compared to medicines for an equally serious condition, the majority of 4,118 people surveyed across Britain said it shouldn't.
Medicines were favoured, however, if they met the criteria by which the value of new medicines is to be assessed as part of the value-based pricing scheme, due to be introduced from January 2014. Treatments were preferred if they were for severe diseases, if they ...
Influenza research: Can dynamic mapping reveal clues about seasonality?
2012-09-07
MEDFORD/SOMERVILLE, Mass. - Influenza outbreaks in the United States typically begin with the arrival of cold weather and then spread in seasonal waves across geographic zones. But the question of why epidemics can vary from one season to the next has baffled scientists.
In a paper titled "Deviations in Influenza Seasonality: Odd Coincidence or Obscure Consequence," Elena Naumova, Ph.D., professor of civil and environmental engineering at Tufts School of Engineering, and collaborators from the U.S. and India suggest that the search for answers has been thwarted, in ...
Needle beam could eliminate signal loss in on-chip optics
2012-09-07
Cambridge, Mass. – September 7, 2012 - An international, Harvard-led team of researchers have demonstrated a new type of light beam that propagates without spreading outwards, remaining very narrow and controlled along an unprecedented distance. This "needle beam," as the team calls it, could greatly reduce signal loss for on-chip optical systems and may eventually assist the development of a more powerful class of microprocessors.
Based at the Harvard School of Engineering and Applied Sciences (SEAS) and the Laboratoire Interdisciplinaire Carnot de Bourgogne, CNRS, in ...
The birdy smell of a compatible partner
2012-09-07
New evidence shows that birds may choose their mate with the help of smell. They prefer a dissimilar mate because this gives their young a more efficient immune system. This has been shown in a new study by researchers from Lund University in Sweden, in a Swedish-French collaboration.
Humans and many animals can choose a suitable mate by smell. Choosing a mate with the right smell can give the offspring an efficient immune system. This is because each individual's smell can be said to reflect information on the individual's genes. By finding the mate whose genes best ...
Measuring glucose without needle pricks
2012-09-07
Sticking yourself in the finger day after day: For many diabetics, this means of checking blood glucose is an everyday part of life. Especially for patients with Type-1 diabetes, who always have to keep a close eye on their levels, since their bodies are incapable of producing the insulin to break down the glucose in the blood. Several times a day, they have to place a tiny drop of blood on a test strip. It is the only way they can ascertain the blood glucose value, so they can inject the correct amount of insulin needed. And this pricking is not only a burdensome: it may ...
LAST 30 PRESS RELEASES:
Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
[Press-News.org] Effective Use of Utah Non-Compete AgreementsDoes your non-compete prevent you from obtaining a new job in your field? You may be able to challenge its terms in court.